Pharmacokinetics and tissue distribution of the new non-imidazole histamine H3 receptor antagonist 1-[3-(4-tert-butylphenoxy) propyl]piperidine in rats

References

• Arrang JM, Garbarg M, Schwartz JC. (1983). Autoinhibition of brain histamine release mediated by a novel class (H3) receptor of histamine. Nature 302:832–7
   PubMed Web of Science ®Google Scholar
• Arrang JM, Morisset S, Gbahou F. (2007). Constitutive activity of the histamine H3 receptor. Trends Pharmacol Sci 28:350–7
   PubMed Web of Science ®Google Scholar
• Baka E, Comer JEA, Takasc-Novak K. (2008). Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 46:335–41
   PubMed Web of Science ®Google Scholar
• Bonaventure P, Letavic M, Dugovic C, et al. (2007). Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 73:1084–96
   PubMed Web of Science ®Google Scholar
• Dahlström BE, Paalzow LK. (1978). Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J Pharmacokinet Biopharm 6:505–19
   PubMedGoogle Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5
   PubMed Web of Science ®Google Scholar
• Gabrielsson J, Weiner D. (1997). Pharmacokinetic and pharmacodynamic data analysis: concepts and applications, 2nd edn. Sweden: Swedish Pharmaceutical Press
   Google Scholar
• Ganellin CR, Leurquin F, Piripitsi A, et al. (1998). Synthesis of potent non-imidazole histamine H3-receptor antagonists. Arch Pharm (Weinheim) 331:395–404
   PubMed Web of Science ®Google Scholar
• Haas HL, Sergeeva O, Selbach O. (2008). Histamine in the nervous system. Physiol Rev 88:1183–241
   PubMed Web of Science ®Google Scholar
• Hancock AA. (2003). H3 receptor antagonists/inverse agonists as anti-obesity agents. Curr Opin Investig Drugs 4:1190–7
   PubMedGoogle Scholar
• Harada C, Hirai T, Fujii Y, et al. (2004). Intracerebroventricular administration of histamine H3 receptor antagonists decreases seizures in rat models of epilepsia. Methods Find Exp Clin Pharmacol 26:263–70
   PubMed Web of Science ®Google Scholar
• Hinderling PH. (1997). Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharm Rev 4:279–95
   Google Scholar
• Ito C. (2004). The role of the central histaminergic system on schizophrenia. Drug News Perspect 17:383–7
   PubMed Web of Science ®Google Scholar
• Komater VA, Buckley MJ, Browman KE, et al. (2005). Effects of histamine H3 receptor antagonists in two models of spatial learning. Behav Brain Res 159:295–300
   PubMed Web of Science ®Google Scholar
• Lazewska D, Ligneau X, Schwartz JC, et al. (2006). Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists. Bioorg Med Chem 14:3522–9
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. (1998). Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35:361–90
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26
   PubMed Web of Science ®Google Scholar
• McConnell EL, Basit AW, Murdan S. (2008). Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol 60:63–70
   PubMed Web of Science ®Google Scholar
• Metsugi Y, Miyaji Y, Ogawara K, et al. (2007). Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function. Pharm Res 25:886–95
   PubMed Web of Science ®Google Scholar
• Ming X, Knight BM, Thakker DR. (2011). Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. Mol Pharm 8:1677–86
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Onodera K, Imaizumi M, Timmerman H. (1997). Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice. Life Sci 61:355–61
   PubMed Web of Science ®Google Scholar
• Pillot C, Héron A, Schwartz JC, Arrang JM. (2003). Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum. Eur J Neurosci 7:307–14
   Google Scholar
• Poli E, Pozzoli C, Coruzzi G. (2001). Role of histamine H3 receptors in the control of gastrointestinal motility. An overview. J Physiology-Paris 95:67–74
   PubMed Web of Science ®Google Scholar
• Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. (2002). Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41:751–90
   PubMed Web of Science ®Google Scholar
• Sjögren E, Hedeland M, Bondesson U, Lennernäs H. (2014). Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs. Eur J Pharm Sci: Off J Eur Feder Pharmaceut Sci 57:214–23
   PubMed Web of Science ®Google Scholar
• Stark H, Kathmann M, Schlicker E, et al. (2004). Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists.Mini Rev Med Chem 4:965–77
   PubMed Web of Science ®Google Scholar
• Stasiak A, Mussur M, Unzeta M, et al. (2011). The central histamine level in rat model of vascular dementia. J Physiol Pharmacol 62:549–58
   PubMed Web of Science ®Google Scholar
• Steinberg SE, Campbell CL, Bleyer WA, Hillman RS. (1982). Enterohepatic circulation of methotrexate in rats in vivo. Cancer Res 42:1279–82
   PubMed Web of Science ®Google Scholar
• Szafarz M, Szymura-Oleksiak J, Lazewska D, Kiec-Kononowicz K. (2011). LC-MS-MS method for the analysis of new non-imidazole histamine H(3) receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine in rat serum-application to pharmacokinetic studies. Chromatographia 73:913–19
   PubMed Web of Science ®Google Scholar
• Szymura-Oleksiak J, Kryczyk A, Szafarz M, et al. (2012). Binding of 1-[3-(4-tert-butyl-phenoxy)propyl]piperidine, a new non imidazole histamine H3 receptor antagonist to bovine serum albumin. Acta Pol Pharm 69:1043–7
   PubMed Web of Science ®Google Scholar
• Vohora D. (2004). Histamine-selective H3 receptor ligands and cognitive functions: an overview. IDrugs 7:667–73
   PubMed Web of Science ®Google Scholar